Bram Goorden
Fortune : 61 368 $ au 31/05/2026
Fortune : 61 368 $ au 31/05/2026
Bram Goorden is currently Chief Executive Officer & Director at Ixico Plc since 2024.
Also holds positions as Chairman at Mantis Photonics AB, Director at Oncobit AG, and Non-Executive Director at Zetta Genomics Ltd. since 2024.
Former roles include Director at Cerecin, Inc., Vice President-International Business at Foundation Medicine, Inc. from 2018 to 2020, Chief Operating Officer & Senior Vice President at SOPHiA GENETICS SA from 2020 to 2022, and General Manager & Head-Therapeutics at Prometheus Labs, Inc. from 2016 to 2018.
Education includes undergraduate studies at Alma Mater Studiorum - Università di Bologna and graduate studies at the University of Antwerp.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IXICO PLC 0,24% | 08/12/2025 | 526 315 ( 0,24% ) | 61 368 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IXICO PLC | Directeur Général | 19/08/2024 |
Mantis Photonics AB
Mantis Photonics AB Packaged SoftwareTechnology Services Develops AI software to detect disease markers | Président | - |
Zetta Genomics Ltd.
Zetta Genomics Ltd. Data Processing ServicesTechnology Services Provides healthcare data management services | Directeur/Membre du Conseil | 27/09/2024 |
Oncobit AG
Oncobit AG Internet Software/ServicesTechnology Services Operates as a monitoring platform | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| SOPHIA GENETICS SA | Directeur des opérations | 31/05/2022 |
| FOUNDATION MEDICINE INC | Corporate Officer/Principal | 01/01/2020 |
Prometheus Labs, Inc.
Prometheus Labs, Inc. Other Consumer ServicesConsumer Services Provides long term valet parking services | Corporate Officer/Principal | 01/01/2018 |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat central nervous system disorders | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat central nervous system disorders | Health Technology |
Ixico Plc
Ixico Plc Miscellaneous Commercial ServicesCommercial Services Operates as a medical imaging company that provides imaging biomarkers for clinical trials, research studies and diagnostics | Commercial Services |
Alma Mater Studiorum - Università di Bologna
Alma Mater Studiorum - Università di Bologna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foundation Medicine, Inc.
Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care | Health Services |
University of Antwerp
University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SOPHiA GENETICS SA
SOPHiA GENETICS SA Packaged SoftwareTechnology Services Develops software services for healthcare industry | Technology Services |
Prometheus Labs, Inc.
Prometheus Labs, Inc. Other Consumer ServicesConsumer Services Provides long term valet parking services | Consumer Services |
Oncobit AG
Oncobit AG Internet Software/ServicesTechnology Services Operates as a monitoring platform | Technology Services |
Zetta Genomics Ltd.
Zetta Genomics Ltd. Data Processing ServicesTechnology Services Provides healthcare data management services | Technology Services |
Mantis Photonics AB
Mantis Photonics AB Packaged SoftwareTechnology Services Develops AI software to detect disease markers | Technology Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national